SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)] [amend]
SEC Accession No. 0001144204-12-032157
Filing Date
2012-05-29
Accepted
2012-05-29 11:51:05
Documents
7
Period of Report
2012-03-31
Filing Date Changed
2012-05-29

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-Q v314455_10qa.htm 10-Q/A 20975
  Complete submission text file 0001144204-12-032157.txt   2192942

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT mslp-20120331.xml EX-101.INS 443538
3 XBRL TAXONOMY EXTENSION SCHEMA mslp-20120331.xsd EX-101.SCH 14294
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mslp-20120331_cal.xml EX-101.CAL 23709
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mslp-20120331_def.xml EX-101.DEF 91956
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE mslp-20120331_lab.xml EX-101.LAB 127497
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mslp-20120331_pre.xml EX-101.PRE 107425
Mailing Address 4721 IRONTON STREET DENVER CO 80239
Business Address 4721 IRONTON STREET DENVER CO 80239 (800) 210-7369
MusclePharm Corp (Filer) CIK: 0001415684 (see all company filings)

IRS No.: 770664193 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-53166 | Film No.: 12873202
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1